Beraprost as initial pharmacologic treatment for pulmonary hypertension related to left to right shunt congenital heart disease

• Main Authors: Shirley Ferlina Lasmono, -, Mahrus A. Rahman, -, I Ketut Alit Utamayasa, -
• Format: Article PeerReviewed
• Language: English; English; English; English; English
• Published: Scientific Publisher of India 2021
• Subjects: R Medicine (General); RJ Pediatrics
• Online Access: https://repository.unair.ac.id/109018/1/Beraprost%20as%20initial%20pharmacologic%20treatment%20for%20pulmonary%20hypertension%20related%20to%20left%20to%20right%20shunt%20congenital%20heart%20disease.pdf; https://repository.unair.ac.id/109018/2/Beraprost%20as%20initial.pdf; https://repository.unair.ac.id/109018/3/Beraprost%20as%20initial%20pharmacologic%20treatment%20for%20pulmonary%20hypertension%20related%20to%20left%20to%20right%20shunt%20congenital%20heart%20disease.pdf; https://repository.unair.ac.id/109018/6/Bukti%20Korespondensi%205.pdf; https://repository.unair.ac.id/109018/7/12%20Karil.pdf; https://repository.unair.ac.id/109018/; https://www.alliedacademies.org/articles/beraprost-as-initial-pharmacologic-treatment-for-pulmonary-hypertension-related-to-left-to-right-shunt-congenital-heart-disease-15477.html
• Institution: Universitas Airlangga

Pulmonary arterial hypertension is a common complication of uncorrected left-to-right shunt congenital heart disease. Beraprost have been used widely to treat pulmonary arterial hypertension in adult. However, the efficacy of the drug in Indonesian children has not been investigated. This study aim...